Li, Jianyong <br/><br/>
Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia.  [electronic resource] 

 -  Oncotarget  Mar 2015 
 - 6448-58 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.3361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aclarubicin--administration & dosage<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Azacitidine--administration & dosage<br/>Cytarabine--administration & dosage<br/>Decitabine<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Prospective Studies<br/>Survival Analysis<br/>Treatment Outcome